HALOPERIDOL

Pre-Launch

haloperidol

PharmaIN

ANDAORALTABLET

Lifecycle

Pre-Launch

Clinical Trials

Data completeness

2/8 — Basic

HALOPERIDOL (haloperidol) by PharmaIN is clinical pharmacology the precise mechanism of action has not been clearly established.

Drug data last refreshed 1mo ago

Mechanism of Action

CLINICAL PHARMACOLOGY The precise mechanism of action has not been clearly established.

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

Clinical Trials (17)

NCT02380118Phase 4Terminated

IM Olanzapine Versus Haloperidol or Midazolam

Started Dec 2014

167 enrolled

Acute Agitation, Behavioural Emergency

NCT01052389Phase 4Completed

Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia

Started Jul 2007

300 enrolled

Schizophrenia

NCT00395915Phase 4Unknown

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia

Started Sep 2006

106 enrolled

Schizophrenia

NCT00457366Phase 4Completed

A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room

Started May 2006

72 enrolled

Agitation

NCT00429676Phase 2Completed

Pilot Study of Haloperidol to Treat Critical Illness Delirium

Started Dec 2005

20 enrolled

DeliriumCritical Illness

Worked on HALOPERIDOL at PharmaIN? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.